CN Patent

CN109180650A — 一种氘代色氨酸羟化酶抑制剂的晶型

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2019-01-11 · 7y expired

What this patent protects

本发明涉及一种氘代色氨酸羟化酶抑制剂的晶型及其制备方法，具体涉及式(I)所示化合物的晶型，及其制备方法。稳定性试验和溶解性试验结果表明，本发明提供的式(I)化合物的晶型符合药用需求。

USPTO Abstract

本发明涉及一种氘代色氨酸羟化酶抑制剂的晶型及其制备方法，具体涉及式(I)所示化合物的晶型，及其制备方法。稳定性试验和溶解性试验结果表明，本发明提供的式(I)化合物的晶型符合药用需求。

Drugs covered by this patent

Patent Metadata

Patent number
CN109180650A
Jurisdiction
CN
Classification
—
Expires
2019-01-11
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Huateng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.